Membrane protein antibody discovery service
GenScript has leveraged its extensive expertise in antibody development to establish an mRNA antigen immune antibody development platform for challenging targets like transmembrane proteins, post-translational modified proteins, difficult expressed proteins and etc
Several challenges persist in membrane protein expression and antibody discovery. Therefore, GenScript proposes the use of mRNA as a viable antigen format for antibody development targeting membrane proteins or proteins which are hard to be expressed.


















